Skip to main content
. 2024 Mar 13;5(5):439–446. doi: 10.1039/d4cb00029c

Fig. 2. (a) Workflow of immunoblot analysis of HA-Ub-VME USP30 labelling following HEK293T treatment with IMP-2587 (b) and IMP-2586 (c) for 1 h. Dose-dependent competition for USP30 labelling occurs for both the ABPs but not with UCHL1 at similar concentration range.

Fig. 2